NCT02159950 2023-04-27
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed
Clinical Trials
6 trialsNCT02057666 2021-04-23
TasQ003
Ipsen
Phase 3 Terminated
NCT01513733 2018-09-04
CATCH
Duke University
Phase 1 Completed
NCT02396368 2015-11-20
Radium-223
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Withdrawn
NCT00560482 2015-10-26
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Active Biotech AB
Phase 2 Completed
NCT01234311 2015-10-21
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Active Biotech AB
Phase 3 Completed